Quality Assurance and Case Ascertainment

(A) For the purpose of assuring the accuracy and completeness of submitted data and to ensure that all cases of malignant disease and benign brain-related tumor disease are reported, each health care facility and health care provider shall allow authorized Cancer Registry staff or agents to inspect and copy such parts of patients' medical records, paper and electronic, as are necessary to assure accurate and complete reporting and to identify any missing required reports. (B) Each health care facility, health care provider, and pharmacist licensed in accordance with M.G.L. c. 112, § 24, shall provide copies of the following records to the Cancer Registry upon request: (1) Reports of all tissue analyses which have been performed for the purpose of determining the presence or absence of malignant disease and benign brain-related tumor disease; (2) Reports (including X-rays) of radiological examinations performed for the purpose of determining the presence or absence of malignant disease and benign brain-related tumor disease; (3) Reports of diagnoses of malignant disease and benign brain-related tumor disease, and notations of the reasons for such diagnoses, including both primary clinicians' reports and consultation reports; (4) Pharmacy records for prescriptions relating to cancer treatment; and (5) Those portions of medical records which contain the specific information required to be reported pursuant to 105 CMR 301.015.